This inventor holds 1 USPTO granted patent and 1 published patent application and 8 EPO patents. Top assignee: Cytoki Pharma Aps. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Henning Thøgersen: Innovator in Therapeutic Derivatives
Introduction
Henning Thøgersen is a notable inventor based in Bagsværd, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents. His work focuses on innovative solutions that have the potential to impact medical treatments.
Latest Patents
Thøgersen holds a patent for "Therapeutic derivatives of interleukin-22." This invention relates to novel derivatives of Interleukin-22 (IL-22), specifically those that include a fatty acid covalently attached to an IL-22 protein. The therapeutic applications of this invention are aimed at enhancing treatment options for various medical conditions.
Career Highlights
Throughout his career, Henning Thøgersen has worked with prominent companies in the biotechnology sector. He has been associated with Cytoki Pharma ApS and Novo Nordisk A/S, where he has contributed to various innovative projects and research initiatives.
Collaborations
Thøgersen has collaborated with several professionals in his field, including Kristian Sass-Ørum and Rasmus Jørgensen. These collaborations have further enriched his research and development efforts.
Conclusion
Henning Thøgersen's work in the field of therapeutic derivatives showcases his commitment to advancing medical science. His innovative approach and collaborations highlight the importance of teamwork in achieving breakthroughs in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile